Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCH and double SH3 domains protein 1 (FCHSD1) is a cytosolic protein containing an amino-terminal F-BAR domain and two C-terminal SH3 domains, distantly related to the formin-binding proteins FNBP1/FNBP2[3][1]. FCHSD1 functions as an actin-regulatory factor, primarily expressed in cuticular plates of sensory hair cells where it influences actin filament organization and maintenance through its interaction with Sorting Nexin 9 (SNX9), enhancing SNX9-mediated, Arp2/3-dependent actin polymerization[1]. FCHSD1 also forms complexes with the transcription factor NRF2 and SNX9 in non-neuronal cells, suppressing NRF2 nuclear translocation, with functional implications in regulating oxidative stress response and emphysema development: its genetic loss in mice protects against lung inflammation and apoptosis in experimental COPD[2]. There are no known drugs targeting FCHSD1, and its direct role as a therapeutic target or as a biomarker remains unestablished.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCH and double SH3 domains protein 1 (FCHSD1).